Skip to main content
. 2024 Nov 4;29(21):5211. doi: 10.3390/molecules29215211

Table 1.

Discriminant metabolites between GNE patients and healthy controls, as determined by the OPLS-DA model, along with their corresponding mass spectrometry characteristics. These characteristics were obtained from the positive ionization mode in the mass spectrometry.

Lipid Adduct m/z exp. m/z theor. Δ (ppm) RT
(min)
Formula DTCCSN2
2)
Theoretical
DTCCSN2
2)
Measured
Deviation of CCS Values
(%)
VIP p Value Regulation in GNE
Acar 16:0 +H+ 400.3418 400.3421 0.75 0.82 C23H45NO4 213.80 213.87 0.03 1.08 0.03
Acar 18:0 +H+ 428.3733 428.3734 0.24 1.14 C25H49NO4 220.50 220.47 −0.01 1.31 0.02
Acar 18:1 +H+ 426.3593 426.3578 3.5 0.99 C25H47NO4 221.90 218.73 −1.43 1.69 0.006
LPC 15:0 +H+ 482.3293 482.3281 2.49 1.08 C23H48NO7P 226.34 231.18 2.14 2.12 0.001
LPC 16:0 +H+ 496.3403 496.3398 1.01 1.12 C24H50NO7P 233.30 231.39 −0.81 1.37 0.007
LPC 17:0 +H+ 510.3573 510.3554 3.71 1.15 C25H52NO7P 236.07 232.52 −1.50 1.14 0.0002
LPC 18:3 +H+ 518.3235 518.3241 −1.16 0.89 C26H48NO7P 224.1 224.05 −0.02 2.19 0.0006
LPC 18:2 +H+ 520.3396 520.3398 0.38 0.98 C26H50NO7P 228.4 227.83 −0.25 1.15 0.005
LPC 18:1 +H+ 522.3552 522.3554 −0.19 1.21 C26H52NO7P 232.92 233.84 0.39 1.02 0.044
LPC 18:0 +H+ 524.3711 524.3713 0.38 1.25 C26H54NO7P 238.53 235.15 −1.42 1.34 0.004
LPC 20:4 +H+ 544.3413 544.3398 2.75 1.18 C28H50NO7P 230.97 234.48 1.51 1.14 0.03
LPC 20:0 +H+ 552.4013 552.4024 −1.99 1.61 C28H58NO7P 248.6 247.00 −0.64 1.15 0.005
PC 16:0_16:1 +H+ 732.5533 732.5538 −0.68 3.32 C40H78NO8P 286.5 282.31 −1.46 1.33 0.008
PC 16:1_18:2 +H+ 756.5563 756.5538 3.30 2.18 C42H78NO8P 282.0 282.88 0.31 1.53 0.02
PC 16:0_18:2 +H+ 758.5673 758.5694 −2.76 3.25 C42H80NO8P 286.5 287.27 0.27 2.23 0.08
PC 16:0_18:0 +H+ 762.5993 762.6007 −1.83 3.67 C42H84NO8P 290.8 291.38 0.20 1.03 0.03
PC 35:1 +H+ 774.6033 774.6007 3.36 2.64 C43H84NO8P 289.8 285.8 −1.38 1.03 ns
PC 35:0 +H+ 776.61953 776.6164 −1.41 3.98 C43H86NO8P 294.3 286.51 −2.65 1.23 ns
PC 18:1_18:2 +H+ 784.5823 784.5851 −3.57 2.69 C44H82NO8P 288.2 292.3 1.42 1.25 ns
PC 18:3_20:0 +H+ 812.6163 812.6164 −0.12 4.63 C46H86NO8P 294.5 296.95 0.83 1.04 0.000006
PC 20:2_20:4 +H+ 834.5983 834.6007 −2.87 3.57 C48H84NO8P 297.6 299.82 0.75 1.15 0.02
SM 32:2 +H+ 673.5303 673.5279 3.56 3.24 C37H73N2O6P 275.00 274.32 −0.25 1.27 ns
SM 18:0_16:0 +H+ 705.5903 705.5905 −0.28 3.44 C39H81N2O6P 288.2 288.72 0.18 1.07 ns
SM 38:1 +H+ 759.6353 759.6365 −1.58 5.95 C43H87N2O6P 296.7 296.13 −0.19 2.81 0.001
SM 40:1 +H+ 787.6663 787.6688 −3.17 6.02 C45H91N2O6P 299.1 302.02 0.98 1.12 0.02
SM 42:2 +H+ 815.7003 815.7001 0.24 7.41 C47H95N2O6P 304.9 303.91 −0.32 1.46 0.004
SM 43:1 +H+ 829.7153 829.7157 −0.48 7.83 C48H97N2O6P 310.7 310.98 0.09 1.09 0.004
TG 14:0_16:1_18:2 +NH4+ 818.7233 818.7232 0.12 12.61 C51H92O6 305.08 306.96 0.38 1.25 ns
TG 14:0_16:1_18:1 +NH4+ 820.7393 820.7389 0.49 13.54 C51H94O6 310.3 310.24 −0.02 1.26 ns
TG 14:0_16:1_18:0 +NH4+ 822.7553 822.7545 0.97 14.09 C51H96O6 311.5 314.41 0.93 1.14 0.01

↑ = upregulated; ↓ = downregulated; ns = not significant.